{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:31:59Z","timestamp":1772915519356,"version":"3.50.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,10,1]]},"DOI":"10.1215\/s115285170300005x","type":"journal-article","created":{"date-parts":[[2004,5,10]],"date-time":"2004-05-10T22:16:47Z","timestamp":1084227407000},"page":"228-234","source":"Crossref","is-referenced-by-count":26,"title":["Preliminary observations on genetic alterations in pilocytic astrocytomas\nassociated with neurofibromatosis 1"],"prefix":"10.1093","volume":"5","author":[{"given":"Kenji","family":"Tada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Saya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ichi","family":"Kuratsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Kamiryo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Shinojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukitaka","family":"Ushio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2003,10,1]]},"reference":[{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Bajenaru, M.L., Zhu, Y., Hedrick, N.M., Donahoe, J., Parada, L.F.,\nand Gutmann, D.H. (2002) Astrocyte-specific inactivation of the\nneurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation.\nMol. Cell Biol.22,5100\n-5113.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Cairncross, J.G., Ueki, K., Zlatescu, M.C., Lisle, D.K.,\nFinkelstein, D.M., Hammond, R.R., Silver, J.S., Stark, P.C., Macdonald, D.R.,\nIno, Y., Ramsay, D.A., and Louis, D.N. (1998) Specific genetic\npredictors of chemotherapeutic response and survival in patients with\nanaplastic oligodendrogliomas. J. Natl. Cancer Inst.90,1473\n-1479.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Cantley, L.C., and Neel, B.G. (1999) New insights into\ntumor suppression: PTEN suppresses tumor formation by restraining the\nphosphoinositide 3-kinase\/Akt pathway. Proc. Natl. Acad. Sci.\nUSA96,4240\n-4245.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Cawthon, R.M., Weiss, R., Xu, G.F., Viskochil, D., Culver, M.,\nStevens, J., Robertson, M., Dunn, D., Gesteland, R., O'Connell, P., and White,\nR. (1990) A major segment of the neurofibromatosis type 1 gene:\ncDNA sequence, genomic structure, and point mutations.\nCell62,193\n-201.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Cheng, Y., Pang, J.C.S., Ng, H.K., Ding, M., Zhang, S.F., Zheng,\nJ., Liu, D.G., and Poon, W.S. (2000) Pilocytic astrocytomas do\nnot show most of the genetic changes commonly seen in diffuse astrocytomas.\nHistopathology37,437\n-444.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Cohen, B.H., Kaplan, A.M., and Packer, R.J.\n(1990-1991) Management of intracranial neoplasms in children with\nneurofibromatosis type 1 and 2. The Children's Cancer Study Group.\nPediatr. Neurosurg.16,66\n-72.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Daston, M.M., Scrable, H., Nordlund, M., Sturbaum, A.K., Nissen,\nL.M., and Ratner, N. (1992) The protein product of the\nneurofibromatosis type 1 gene is expressed at highest abundance in neurons,\nSchwann cells and oligodendrocytes. Neuron8, 415-428.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"DeClue, J.E., Cohen, B.D., and Lowy, D.R. (1991)\nIdentification and characterization of the neurofibromatosis type 1 gene\nproduct. Proc. Natl. Acad. Sci. USA88,9914\n-9918.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Di Cristofano, A., and Pandolfi, P.P. (2000) The\nmultiple roles of PTEN in tumor suppression. Cell100,387\n-390.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Duerr, E.M., Rollbrocker, B., Hayashi, Y., Peters, N.,\nMeyer-Puttlitz, B., Louis, D.N., Schramm, J., Wiestler, O.D., Parsons, R.,\nEng, C., and von Deimling, A. (1998) PTEN mutations in gliomas\nand glioneuronal tumors. Oncogene16,2259\n-2264.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Figarella-Branger, D., Daniel, L., Andre, P., Guia, S., Renaud, W.,\nMonti, G., Vivier, E., and Rougon, G. (1999) The PEN5 epitope\nidentifies an oligodendrocyte precursor cell population and pilocytic\nastrocytomas. Am. J. Pathol.155,1261\n-1269.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Friedman, J.M., Gutmann, D.H., MacCollin, M., and Riccardi, V.M.\n(Eds.) (1999) Neurofibromatosis: Phenotype, Natural\nHistory and Pathogenesis, 3rd ed., Baltimore, Md.: Johns Hopkins\nUniversity Press.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Gutmann, D.H., Wood, D.L., and Collins, F.S. (1991)\nIdentification of the neurofibromatosis type 1 gene product. Proc.\nNatl. Acad. Sci. USA88,9658\n-9662.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Gutmann, D.H., Giordano, M.J., Mahadeo, D.K., Lau, N., Silbergeld,\nD., and Guha, A. (1996) Increased neurofibromatosis 1 gene\nexpression in astrocytic tumors: Positive regulation by p21-ras.\nOncogene12,2121\n-2127.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Gutmann, D.H., Aylsworth, A., Carey, J.C., Korf, B., Marks, J.,\nPyeritz, R.E., Rubenstein, A., and Viskochil, D. (1997) The\ndiagnostic evaluation and multidisciplinary management of neurofibromatosis 1\nand neurofibromatosis 2. JAMA278, 51-57.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Gutmann, D.H., Donahoe, J., Brown, T., James, C.D., and Perry, A.\n(2000) Loss of neurofibromatosis 1 (NF1) gene expression in\nNF1-associated pilocytic astrocytomas. Neuropathol. Appl.\nNeurobiol.26,361\n-367.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Gutmann, D.H., Hedrick, N.M., Li, J., Nagarajan, R., Perry, A., and\nWatson, M.A. (2002) Comparative gene expression profile analysis\nof neurofibromatosis 1-associated and sporadic pilocytic astrocytomas.\nCancer Res.62,2085\n-2091.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Holland, E.C., Celestino, J., Dai, C., Schaefer, L., Sawaya, R.E.,\nand Fuller, G.N. (2000) Combined activation of Ras and Akt in\nneural progenitors induces glioblastoma formation in mice. Nat.\nGenet.25,55\n-57.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Huson, S.M., and Hughes, R.A.C. (Eds.) (1994)\nThe Neurofibromatoses: A Pathogenetic and Clinical\nOverview. New York: Chapman and Hall Medical.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Ilgren, E.B., and Stiller, C.A. (1987) Cerebellar\nastrocytomas. Part II. Pathologic features indicative of malignancy.\nClin. Neuropathol.6,201\n-214.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Kamiryo, T., Tada, K., Shiraishi, S., Shinojima, N., Nakamura, H.,\nKochi, M., Kuratsu, J., Saya, H., and Ushio, Y. (2002) Analysis\nof homozygous deletion of the p16 gene and correlation with survival in\npatients with glioblastoma multiforme. J. Neurosurg.96,815\n-822.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Kleihues, P., and Ohgaki, H. (1999) Primary and\nsecondary glioblastomas: From concept to clinical diagnosis.\nNeuro-Oncology1,44\n-51.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Kleihues, P., and Cavenee, W.K. (Eds.) (2000)\nPathology and Genetics of Tumours of the Nervous\nSystem (World Health Organization Classification of Tumours).\nLyon, France: IARC Press.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Kluwe, L., Hagel, C., Tatagiba, M., Thomas, S., Stavrou, D.,\nOstertag, H., von Deimling, A., and Mautner, V.F. (2001) Loss of\nNF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas.\nJ. Neuropathol. Exp. Neurol.60,917\n-920.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Lau, N., Feldkamp, M.M., Roncari, L., Loehr, A.H., Shannon, P.,\nGutmann, D.H., and Guha, A. (2000) Loss of neurofibromin is\nassociated with activation of RAS\/MAPK and PI3-K\/AKT signaling in a\nneurofibromatosis 1 astrocytoma. J. Neuropathol. Exp.\nNeurol.59,759\n-767.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S.I.,\nPuc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S.H., Giovanella,\nB.C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M.H., and Parsons, R.\n(1997) PTEN, a putative protein tyrosine phosphatase gene mutated\nin human brain, breast, and prostate cancer. Science275,1943\n-1947.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Li, J., Perry, A., James, C.D., and Gutmann, D.H.\n(2001) Cancer-related gene expression profiles in NF1-associated\npilocytic astrocytomas. Neurology56,885\n-890.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Listernick, R., Louis, D.N., Packer, R.J., and Gutmann, D.H.\n(1997) Optic pathway gliomas in children with neurofibromatosis\n1: Consensus statement from the NF1 Optic Pathway Glioma Task Force.\nAnn. Neurol.41,143\n-149.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Listernick, R., Charrow, J., and Gutmann, D.H. (1999)\nIntracranial gliomas in neurofibromatosis type 1. Am. J. Med.\nGenet.89,38\n-44.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Ly, D.H., Lockhart, D.J., Lerner, R.A., and Schultz, P.G.\n(2000) Mitotic misregulation and human aging.\nScience287,2486\n-2492.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Molloy, P.T., Bilaniuk, L.T., Vaughan, S.N., Needle, M.N., Liu,\nG.T., Zackai, E.H., and Phillips, P.C. (1995) Brainstem tumors in\npatients with neurofibromatosis type 1: A distinct clinical entity.\nNeurology45,1897\n-1902.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Nielsen, G.P., Stemmer-Rachamimov, A.O., Ino, Y., Moller, M.B.,\nRosenberg, A.E., and Louis, D.N. (1999) Malignant transformation\nof neurofibromas in neurofibromatosis 1 is associated with CDKN2A\/p16\ninactivation. Am. J. Pathol.155,1879\n-1884.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"NIH. National Institutes of Health Consensus Development\nConference. (1988) Neurofibromatosis: Conference statement.\nArch. Neurol.45,575\n-578.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Okutani, T., Okabayashi, Y., Kido, Y., Sugimoto, Y., Sakaguchi, K.,\nMatuoka, K., Takenawa, T., and Kasuga, M. (1994) Grb2\/Ash binds\ndirectly to tyrosines 1068 and 1086 and indirectly to tyrosine 1148 of\nactivated human epidermal growth factor receptors in intact cells.\nJ. Biol. Chem.269,31310\n-31314.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Ruggieri, M., and Packer, R.J. (2001) Why do benign\nastrocytomas become malignant in NF1? Neurology56,827\n-829.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Shiraishi, S., Tada, K., Nakamura, H., Makino, K., Kochi, M., Saya,\nH., Kuratsu, J., and Ushio, Y. (2002) Influence of p53 mutations\non prognosis of patients with glioblastoma. Cancer95,249\n-257.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Steck, P.A., Pershouse, M.A., Jasser, S.A., Yung, W.K., Lin, H.,\nLigon, A.H., Langford, L.A., Baumgard, M.L., Hattier, T., Davis, T., Frye, C.,\nHu, R., Swedlund, B., Teng, D.H., and Tavtigian, S.V. (1997)\nIdentification of a candidate tumour suppressor gene, MMAC1, at chromosome\n10q23.3 that is mutated in multiple advanced cancers. Nat.\nGenet.15,356\n-362.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Tada, K., Shiraishi, S., Kamiryo, T., Nakamura, H., Hirano, H.,\nKuratsu, J., Kochi, M., Saya, H., and Ushio, Y. (2001) Analysis\nof loss of heterozygosity on chromosome 10 in patients with malignant\nastrocytic tumors: Correlation with patient age and survival. J.\nNeurosurg.95,651\n-659.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Viskochil, D., Buchberg, A.M., Xu, G., Cawthon, R.M., Stevens, J.,\nWolff, R.K., Culver, M., Carey, J.C., Copeland, N.G., Jenkins, N.A., White,\nR., and O'Connell, P. (1990) Deletions and a translocation\ninterrupt a cloned gene at the neurofibromatosis type 1 locus.\nCell62,187\n-192.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Wallace, M.R., Marchuk, D.A., Andersen, L.B., Letcher, R., Odeh,\nH.M., Saulino, A.M., Fountain, J.W., Brereton, A., Nicholson, J., Mitchell,\nA.L., Brownstein, B.H., and Collins, F.S. (1990) Type 1\nneurofibromatosis gene: Identification of a large transcript disrupted in\nthree NF1 patients [erratum in Science250, 1749, 1990].\nScience249,181\n-186.","DOI":"10.1006\/excr.2000.5138"},{"key":"key\n\t\t\t\t20171013123559_","doi-asserted-by":"crossref","unstructured":"Zhu, Y., and Parada, L.F. (2001) Neurofibromin, a\ntumor suppressor in the nervous system. Exp. Cell Res.264, 19-28.","DOI":"10.1006\/excr.2000.5138"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/5\/4\/228\/13065980\/02-NO5.4Tada.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T16:37:09Z","timestamp":1507912629000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article\/5\/4\/228\/1102530\/Preliminary-observations-on-genetic-alterations-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,1]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2003,10,1]]},"published-print":{"date-parts":[[2003,10,1]]}},"URL":"https:\/\/doi.org\/10.1215\/s115285170300005x","relation":{},"ISSN":["1523-5866","1522-8517"],"issn-type":[{"value":"1523-5866","type":"electronic"},{"value":"1522-8517","type":"print"}],"subject":[],"published-other":{"date-parts":[[2003,10]]},"published":{"date-parts":[[2003,10,1]]}}}